| Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of … Y Ingrasciotta, A Spini, L L'Abbate, ES Fiore, M Carollo, V Ientile, V Isgrò, ... Pharmacological Research 200, 107074, 2024 | 13 | 2024 |
| Myasthenia gravis treatment: from old drugs to innovative therapies with a glimpse into the future S Crisafulli, B Boccanegra, M Carollo, E Bottani, P Mantuano, G Trifirò, ... CNS drugs 38 (1), 15-32, 2024 | 10 | 2024 |
| Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium M Carollo, V Boccardi, S Crisafulli, V Conti, P Gnerre, S Miozzo, ... Aging Clinical and Experimental Research 36 (1), 63, 2024 | 7 | 2024 |
| Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus F Piarulli, C Banfi, E Ragazzi, E Gianazza, M Munno, M Carollo, P Traldi, ... Cardiovascular Diabetology 23 (1), 36, 2024 | 7 | 2024 |
| Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis M Carollo, S Crisafulli, G Vitturi, M Besco, D Hinek, A Sartorio, V Tanara, ... Journal of the American Geriatrics Society, 2024 | 6 | 2024 |
| Agreement of different drug-drug interaction checkers for proton pump inhibitors M Carollo, S Crisafulli, M Selleri, L Piccoli, L L’Abbate, G Trifirò JAMA network open 7 (7), e2419851-e2419851, 2024 | 5 | 2024 |
| Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from … A Spini, L L’Abbate, Y Ingrasciotta, G Pellegrini, M Carollo, V Ientile, ... Clinical Epidemiology, 395-407, 2024 | 4 | 2024 |
| Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities S Crisafulli, F Ciccimarra, C Bellitto, M Carollo, E Carrara, L Stagi, R Triola, ... Frontiers in Drug Safety and Regulation 4, 1356405, 2024 | 3 | 2024 |
| Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants M Carollo, S Crisafulli, F Ciccimarra, G Andò, I Diemberger, G Trifirò Expert Opinion on Drug Metabolism & Toxicology 20 (3), 157-164, 2024 | 3 | 2024 |
| The promise of N‐acetylcysteine in the treatment of obsessive‐compulsive disorder M Carollo, N Carollo, G Montan CNS Neuroscience & Therapeutics 30 (2), 2024 | 2 | 2024 |
| Circulating Factors as Potential Biomarkers of Cardiovascular Damage Progression Associated with Type 2 Diabetes G Sartore, F Piarulli, E Ragazzi, A Mallia, S Ghilardi, M Carollo, A Lapolla, ... Proteomes 12 (4), 29, 2024 | 1 | 2024 |
| Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network A Spini, G Pellegrini, Y Ingrasciotta, L L’Abbate, C Bellitto, M Carollo, ... Expert Opinion on Biological Therapy, 2024 | 1 | 2024 |
| Gap junction modulators: prospects in bupropion cardiotoxicity L Losso, M Carollo, G Ricci Medical Hypotheses 185, 111296, 2024 | 1 | 2024 |
| Hair toxicological analysis of infants and their mothers: a 5-year retrospective study focusing on cocaine C Cestonaro, C Terranova, M Carollo, A Russo, M Rosa-Rizzotto, G Viel, ... International Journal of Legal Medicine, 1-8, 2024 | 1 | 2024 |
| “Heavy Metal”: Management of lead toxicity following a gunshot injury with retained lead fragments, a case report I Costantini, M Carollo, L Losso, E Morando, M Bacchion, G Mantelli, ... Toxicology reports 11, 444-448, 2023 | 1 | 2023 |
| Association of renin-angiotensin-aldosterone system inhibitors with best COVID-19 outcomes in a diabetic population of the Veneto region (north-east Italy): A lesson for … F Piarulli, E Ragazzi, M Carollo, L Benacchio, F Piovanello, I Simoncello, ... Nutrition, Metabolism, and Cardiovascular Diseases, 2023 | 1 | 2023 |
| Androgens and Female Sexuality: Molecular Insights, Neuroendocrine Crosstalk and Future Therapeutic Directions G Montan, M Carollo, L Torres, G Buzzaccarini, A Giannini, A Etrusco, ... Clinical and Experimental Obstetrics & Gynecology 50 (7), 2023 | 1 | 2023 |
| Comment on “Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory … A Spini, L L’Abbate, Y Ingrasciotta, G Pellegrini, M Carollo, V Ientile, ... Clinical Epidemiology, 445-446, 2024 | | 2024 |
| Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer G Spagnol, S Bigardi, M Zorzi, M Morotti, M Carollo, GM Bruni, ... Journal of clinical medicine 13 (22), 6915, 2024 | | 2024 |
| Reversal of dabigatran and apixaban-induced coagulopathy using idarucizumab, fibrinogen, and prothrombin complex concentrate: A case report E Morando, L Losso, M Carollo, I Costantini, M Bacchion, L Drezza, ... Heliyon 10 (21), 2024 | | 2024 |
